Spectral AI, Inc. Share Price

MDAI

US84757T1051

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 20:15:26 15/07/2026 BST			5-day change	1st Jan Change
1.685 ^USD	+0.90%		-2.60%	+18.66%

07-08	Spectral Ai, Inc. Announces Appointment of Darcy Bajko to Chief Commercial Officer, Effective July 31, 2026	CI
06-29	Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell Microcap Value Benchmark Index	CI

Latest news : Spectral AI, Inc.

07-08	Spectral Ai, Inc. Announces Appointment of Darcy Bajko to Chief Commercial Officer, Effective July 31, 2026	CI
06-29	Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell Microcap Value Benchmark Index	CI
06-28	Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell 3000E Value Benchmark	CI
05-26	Spectral Ai Receives FDA De Novo Clearance for DeepView System for Burn Indication	CI
05-26	Spectral Ai receives FDA De Novo clearance for Deepview® system for burn indication	RE
05-12	Spectral AI Inc - forecasts FY2026 revenue of about $18.5 million	RE
05-12	Spectral AI, Inc., Q1 2026 Earnings Call, May 12, 2026
05-12	Spectral AI, Inc. Reiterates Revenue Guidance for the Year Ending December 31, 2026	CI
05-12	Spectral AI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-08	Spectral AI, Inc. Appoints David Mcguire as Chief Financial Officer, Effective May 4, 2026	CI
04-08	Spectral AI names David McGuire, CPA, as chief financial officer	RE
03-25	Spectral AI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-24	Spectral AI, Inc., Q4 2025 Earnings Call, Mar 24, 2026

More news

Last Transcript: Spectral AI, Inc.

Spectral AI, Inc., Q1 2026 Earnings Call, May 12, 2026

05-12

More transcripts

Analysts' recommendations: Spectral AI, Inc.

18/07/24	HC Wainwright Initiates Spectral AI at Buy Rating With $3.50 Price Target	MT
23/01/24	BTIG Initiates Spectral AI at Buy Rating With $4 Price Target	MT

More recommendations

Press Releases: Spectral AI, Inc.

07-08	Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication	GL
06-25	DeepView® System Highlighted at the 2026 British Burn Association Annual Conference	GL
06-12	Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month	GL
06-11	Spectral AI to Participate in 2026 British Burn Association Annual Conference	GL
06-01	Spectral AI Announces Voting Results of Annual Meeting of Stockholders	GL

More press releases

Managers and Directors: Spectral AI, Inc.

Manager	Title	Age	Since
Wen Sheng Fan CEO	Chief Executive Officer	57	10/09/2023
Vincent Capone CEO	Chief Executive Officer	59	08/02/2026
David McGuire DFI	Director of Finance/CFO	47	03/05/2026

Director	Title	Age	Since
Richard Cotton CHM	Chairman	65	10/09/2023
Martin Mellish BRD	Director/Board Member	68	31/05/2021
John DiMaio CHM	Chairman	70	16/11/2020

More insiders

Medical Software & Technology Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPECTRAL AI, INC.	+0.90%	-2.60%	-40.04%	-84.22%	53.15M
VEEVA SYSTEMS INC.	+0.44%	+2.99%	-30.62%	-6.32%	31.37B
PRO MEDICUS LIMITED	-1.14%	-8.60%	-39.24%	+194.12%	14.22B
SECTRA AB	-0.98%	+0.21%	-22.30%	+70.93%	5.7B
HEARTFLOW, INC.	+7.69%	+4.63%	-	-	2.2B
OMNICELL, INC.	+2.53%	+3.90%	+72.10%	-34.30%	2.09B
GENERATE BIOMEDICINES, INC.	-0.70%	-10.78%	-	-	1.82B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	+0.58%	-2.03%	-30.67%	-	1.07B
ARBUTUS BIOPHARMA CORPORATION	-1.19%	-13.60%	+44.09%	+100.44%	911M
RAYSEARCH LABORATORIES AB	-1.33%	-2.02%	-38.26%	+235.14%	805M
Average	+0.64%	-4.39%	-10.62%	+67.97%	6.02B
Weighted average by Cap.	+0.26%	-2.46%	-27.05%	+57.52%

See all sector performances

Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
15/07/26	US$1.685	+0.90%	105,346
14/07/26	US$1.670	-0.60%	84,865
13/07/26	US$1.680	-2.33%	192,886
10/07/26	US$1.720	0.00%	252,838
09/07/26	US$1.720	-0.58%	116,791

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Cap	53.15M 46.47M 42.86M 39.4M 74.66M 5.11B 75.94M 512M 201M 2.5B 200M 195M 8.62B	P/E 2026 *	-2.98x	P/E 2027 *	-5.96x
Enterprise Value	53.15M 46.47M 42.86M 39.4M 74.66M 5.11B 75.94M 512M 201M 2.5B 200M 195M 8.62B	EV / Sales 2026 *	2.85x	EV / Sales 2027 *	1.28x
Free-Float	87.03%	Yield 2026 *	-	Yield 2027 *	-

1 day	+0.90%
1 week	-2.60%
Current month	-2.60%
1 month	-8.42%
3 months	-11.78%
6 months	+4.66%
Current year	+18.66%

1 week	1.66	1.76
1 month	1.62	1.9
Current year	1.18	2.97
1 year	1.18	2.97
3 years	0.82	19.5
5 years	0.82	19.5
10 years	0.82	19.5

Date	Insider	Type	Main position	Quantity	% Market Cap.
06-28	John DiMaio	Free	Founder	15,000	0.0471%
05-28	John DiMaio	Free	Founder	15,000	0.0471%
05-25	John Michael Dimaio	Free	Director	32,233	0.1013%

	2026 *	2027 *
Net sales	18.68M 16.33M 15.06M 13.85M 26.23M 1.8B 26.68M 180M 70.55M 878M 70.13M 68.6M 3.03B	41.37M 36.17M 33.36M 30.67M 58.11M 3.98B 59.11M 398M 156M 1.95B 155M 152M 6.71B
Net income	-18.69M -16.34M -15.07M -13.85M -26.25M -1.8B -26.7M -180M -70.6M -879M -70.18M -68.64M -3.03B	-10.58M -9.25M -8.54M -7.85M -14.87M -1.02B -15.12M -102M -39.99M -498M -39.75M -38.88M -1.72B
Net Debt	-	-

Spectral AI, Inc. Share Price

Stocks

MDAI

US84757T1051

Advanced Medical Equipment & Technology

Valuation: Spectral AI, Inc.

Chart: Spectral AI, Inc.

Latest news : Spectral AI, Inc.

Last Transcript: Spectral AI, Inc.

Analysts' recommendations: Spectral AI, Inc.

Press Releases: Spectral AI, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Spectral AI, Inc.

Latest insider transactions

Medical Software & Technology Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Quarterly revenue - Rate of surprise